ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted August 08, 2022

Seller of CBD Warned for COVID-19 Claims

On August 4, 2022, the FDA sent a warning letter to FluxxLab LLC following a review of the company’s website and social media which found statements about the company’s Covid-19 Immune Support Tincture and CBDA+CBD Oil Tincture products to be drug claims because they are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/